Gang Xu

Developing an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum Albumin.

Tongfu Yang, Zhenlei Zhang, Hong Liang, 2023, Journal of medicinal chemistry.

Developing a Multitargeted Anticancer Palladium(II) Agent Based on the His-242 Residue in the IIA Subdomain of Human Serum Albumin.

Wenjuan Li, Zhenlei Zhang, Hong Liang, 2023, Journal of medicinal chemistry.

Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of Cancer.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2023, Journal of medicinal chemistry.

Developing a Hetero-Trinuclear Erbium(III)-Copper(II) Complex Based on Apoferritin: Targeted Photoacoustic Imaging and Multimodality Therapy of Tumor.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2023, Journal of medicinal chemistry.

Developing a Ruthenium(III) Complex to Trigger Gasdermin E-Mediated Pyroptosis and an Immune Response Based on Decitabine and Liposomes: Targeting Inhibition of Gastric Tumor Growth and Metastasis.

Tongfu Yang, Wenjuan Li, Zhenlei Zhang, 2023, Journal of medicinal chemistry.

A novel Au(III) agent designed to inhibit tumor growth and metastasis through inducing immunogenic cell death

Wenjuan Li, Zhenlei Zhang, Shanhe Li, 2024, Rare Metals.

Rational Design of a Hetero-multinuclear Gadolinium(III)-Copper(II) Complex: Integrating Magnetic Resonance Imaging, Photoacoustic Imaging, Mild Photothermal Therapy, Chemotherapy and Immunotherapy of Cancer.

Wenjuan Li, Zhenlei Zhang, Shanhe Li, 2024, Journal of medicinal chemistry.